HAVCR1 and systemic lupus erythematosus: This study aims to evaluate the potential relationship between serum and urinary levels of KIM-1 and β2MG and (a) disease activity, and (b) the development of tissue lesions (including renal damage, hematological abnormalities, and skin lesions) in SLE patients.